Cargando…

Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes

BACKGROUND: Inter-individual differences in opioid sensitivity may underlie different opioid risk profiles but have often been researched in persons who have current or past opioid use disorder or physical dependence. This study examined how opioid sensitivity manifests across various assessments of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durgin, Caitlyn J., Huhn, Andrew S., Bergeria, Cecilia L., Finan, Patrick H., Campbell, Claudia M., Antoine, Denis G., Dunn, Kelly E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507188/ https://www.ncbi.nlm.nih.gov/pubmed/37731966 http://dx.doi.org/10.1016/j.dadr.2023.100188

Ejemplares similares

Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model
por: Dunn, Kelly E., et al.
Publicado: (2021)

Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
por: Campbell, Claudia M., et al.
Publicado: (2023)

Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
por: Anderson Goodell, Erin M., et al.
Publicado: (2021)

Evaluation of Stigma Related to Perceived Risk for Coronavirus-19 Transmission Relative to the Other Stigmatized Conditions Opioid Use and Depression
por: Okobi, Sandra, et al.
Publicado: (2022)

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions
por: Grubb, Caitlyn J., et al.
Publicado: (2021)

Operational definition of precipitated opioid withdrawal
por: Dunn, Kelly E., et al.
Publicado: (2023)

Ghrelin Exerts Analgesic Effects through Modulation of IL-10 and TGF-β Levels in a Rat Model of Inflammatory Pain
por: Azizzadeh, Faranak, et al.
Publicado: (2017)

Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Preventing depression: Qualitatively examining the benefits of depression-focused iCBT for participants who do not meet clinical thresholds
por: Earley, C., et al.
Publicado: (2017)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study)
por: Mäkelä, Sanna M., et al.
Publicado: (2023)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Bacterial DNA Detection in the Blood of Healthy Subjects
por: Raeisi, Javad, et al.
Publicado: (2022)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans
por: Dunn, Kelly E., et al.
Publicado: (2019)

Documenting limited health literacy in a clinical setting()
por: Nguyen, Julie, et al.
Publicado: (2022)

Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose
por: Sosnowski, David W., et al.
Publicado: (2022)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

Negative attitudes about medications for opioid use disorder among criminal legal staff
por: Moore, Kelly E., et al.
Publicado: (2022)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

The First Report of Differences in Gut Microbiota Composition between Obese and Normal Weight Iranian Subjects
por: Ettehad Marvasti, Fateme, et al.
Publicado: (2020)

Signal of increased opioid overdose during COVID-19 from emergency medical services data
por: Slavova, Svetla, et al.
Publicado: (2020)

Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Improving integrative 3D modeling into low‐ to medium‐resolution electron microscopy structures with evolutionary couplings
por: McCafferty, Caitlyn L., et al.
Publicado: (2021)

The Predictive Value of Serum Cytokines for Distinguishing Celiac Disease from Non-Celiac Gluten Sensitivity and Healthy Subjects
por: Masaebi, Fatemeh, et al.
Publicado: (2020)

Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017
por: Khachikian, Tenie, et al.
Publicado: (2022)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

Trends in opioid overdose fatalities in Cuyahoga County, Ohio: Multi-drug mixtures, the African-American community and carfentanil
por: Bhullar, Manreet K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82v320ej4f357ksulo4a839rof